UK markets closed

Formosa Pharmaceuticals, Inc. (6838.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
55.30+2.10 (+3.95%)
At close: 02:59PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 7.42B
Enterprise value 6.27B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)44.95
Price/book (mrq)6.71
Enterprise value/revenue 39.45
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-8.53%
S&P500 52-week change 326.36%
52-week high 366.90
52-week low 349.00
50-day moving average 354.25
200-day moving average 352.47

Share statistics

Avg vol (3-month) 3408.29k
Avg vol (10-day) 3129.99k
Shares outstanding 5134.14M
Implied shares outstanding 6134.65M
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-907.98%

Management effectiveness

Return on assets (ttm)-13.58%
Return on equity (ttm)-40.04%

Income statement

Revenue (ttm)31.17M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -247.53M
Net income avi to common (ttm)-321.96M
Diluted EPS (ttm)-2.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.22B
Total cash per share (mrq)9.07
Total debt (mrq)29.79M
Total debt/equity (mrq)2.61%
Current ratio (mrq)4.99
Book value per share (mrq)8.50

Cash flow statement

Operating cash flow (ttm)-196.04M
Levered free cash flow (ttm)9.74M